Live Chat ×
Skip to main content

What is MDS? From Diagnosis to Treatment

Dr. Amer Zeidan, an MDS expert from Yale School of Medicine, uses a number of real-life case studies to help you understand MDS and its treatment. During this program he explains MDS, discusses possible causes and defines symptoms you might experience. He also covers treatment options for both lower and higher-risk MDS. This includes drug therapies approved specifically to treat MDS, such as chemotherapies, stem cell transplantation, and supportive care therapies like blood transfusions and growth factors. He ends with some practical tips for taking charge of your care.

By the end of this program, you will be able to understand:

  • The difference between low-risk and high risk MDS
  • MDS classification and scoring systems and what they mean in regards to your diagnosis
  • Your treatment options as well as the advances in MDS treatment, particularly bone marrow transplants in older MDS patients
  • The relationship between MDS, acute myeloid leukemia (AML), CMML, and MPNs
  • What personalized medicine means in relationship to MDS
  • How to take an active role in your care
This webinar is brought to you by Celgene and Takeda.